Radiation boost after immunotherapy shows promise against tough esophageal cancer
NCT ID NCT07152678
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 24 times
Summary
This study tests whether adding a precise, high-dose internal radiation treatment (brachytherapy) after standard external radiation, chemotherapy, and the immunotherapy drug nivolumab can help prevent esophageal cancer from coming back. About 60 adults with advanced esophageal squamous cell carcinoma that did not fully respond to initial treatment will receive 1-2 brachytherapy sessions. Researchers will track cancer recurrence and side effects for 12 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital Yunlin Branch
RECRUITINGHuwei, Yunlin County, 632, Taiwan
Conditions
Explore the condition pages connected to this study.